Selected trends in the US medical cannabis market
The major American cannabis companies will focus on expanding their presence in the domestic cannabis therapy market, but after a short period of time it will be possible to feel the feeling of
the opportunities to enter Asian and European markets.
The pages of the specialized electronic edition of Ukrainian hemp growers have repeatedly described the rapidly developing processes in the field of cannabinoid medicine in Canada, Israel, and some European countries. In this material, some tendencies of the cannabinide medicine market, which is actively developing in the territory of the richest country in the world, will be demonstrated with strokes.
It should be noted at once that the top five leaders of the U.S. hemp market is not static, for example, Green Thumb Industries has recently broken into the leaders and continues to rapidly increase its presence through aggressive expansionist policies. As of early January 2019, Curaleaf, Green Thumb Industries, MedMen, Acreage Holdings and Trulieve.
are the largest publicly traded multi-business hemp companies with the largest market capitalization in the U.S.
• Curaleaf (market capitalization of $2.6 billion) operates in 11 states. The company operates the largest cannabinoid therapy service delivery system in the United States, including 42 dispensaries, 12 cultivation facilities, and 10 processing facilities.
• Green Thumb Industries (market capitalization $ 1.8 billion). Operates 12 objects specializing in cultivation and 85 dispensaries in 10 states.
• MedMen (market capitalization of $1.5 billion) is present in 12 states through the operation of 16 facilities specializing in therapeutic cannabis cultivation and processing and managing 76 cannabis retail stores.
• Acreage Holdings (market capitalization $ 1.3 billion) – operates 15 facilities specializing in cannabis cultivation, and supervises 78 dispensaries in 19 states.
• Trulieve (market capitalization $994 million) operates in California, Massachusetts, Florida (manages 23 dispensaries in the state).
Presence of the largest publicly traded US companies in various US administrative units



Association Commentary on Ukrainian Technical Hemp
The American market for cannabinoid therapy services is clearly fragmented. Despite the dominance of local players in individual states, there is a trend towards market consolidation and consolidation (over the past 5 years, more than 300 mergers and acquisitions have been completed).
The major American hemp companies will focus on expanding their presence on the domestic market of cannabinoid therapy, but after a short period of time they will be able to feel the feeling of the opportunity to enter Asian and European markets.